As filed with the Securities and Exchange Commission on September 4, 2003
Registration No. 333-________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
Under
The Securities Act of 1933
KOSAN BIOSCIENCES INCORPORATED
(Exact name of Registrant as specified in its charter)
Delaware | 3832 Bay Center Place Hayward, CA 94545 (510) 732-8400 | 94-3217016 | ||
(State of incorporation) | (Address of principal executive offices) | (I.R.S. Employer Identification Number) |
1996 STOCK OPTION PLAN
2000 EMPLOYEE STOCK PURCHASE PLAN
(Full title of the plans)
Daniel V. Santi, M.D., Ph.D.
Chairman and Chief Executive Officer
Kosan Biosciences Incorporated
3832 Bay Center Place
Hayward, CA 94545
(510) 732-8400
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copy to:
Suzanne Sawochka Hooper, Esq.
COOLEY GODWARDLLP
Five Palo Alto Square
3000 El Camino Real
Palo Alto, CA 94306
(650) 843-5000
CALCULATION OF REGISTRATION FEE
Title of Each Class of Securities to be Registered | Amount to be Registered (1) | Proposed Maximum Offering Price Per Share (2) | Proposed Maximum Aggregate Offering Price (2) | Amount of Registration Fee | ||||
Stock options and common stock | 650,000 shares | $8.49 | $5,518,500 | $446.45 |
(1) | In addition, pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional shares of Kosan’s common stock that become issuable under the 1996 Stock Option Plan and 2000 Employee Stock Purchase Plan by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without Kosan’s receipt of consideration that results in an increase in the number of Kosan’s outstanding shares of common stock. |
(2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and (h)(l) under the Securities Act. The offering price per share and aggregate offering price for the unissued stock options and common stock are based upon the average of the high and low prices of Kosan’s common stock as reported on the Nasdaq National Market on September 3, 2003. |
EXPLANATORY NOTE
This Registration Statement on Form S-8 is being filed for the purpose of registering (i) an additional 500,000 shares of common stock of Kosan Biosciences Incorporated (“Kosan”) to be issued pursuant to options under Kosan’s 1996 Stock Option Plan, as amended, and (ii) an additional 150,000 shares of common stock of Kosan to be issued under Kosan’s 2000 Employee Stock Purchase Plan.
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The contents of the Registration Statement on Form S-8 (relating to the 1996 Stock Option Plan, 2000 Employee Stock Purchase Plan and 2000 Non-Employee Director Stock Option Plan) File No. 333-47758 and the Registration Statements on Form S-8 (relating to the 1996 Stock Option Plan) File Nos. 333-63534 and 333-96669, previously filed with the Securities and Exchange Commission on October 11, 2000, June 21, 2001 and July 18, 2002, respectively, are incorporated by reference herein.
EXHIBITS
Exhibit Number | Description | ||
4.1 | (1) | Amended and Restated Certificate of Incorporation of Registrant, as amended to date. | |
4.2 | (2) | Amended and Restated Bylaws of Registrant. | |
4.3 | (3) | Specimen of Common Stock Certificate. | |
5.1 | Opinion of Cooley Godward LLP. | ||
23.1 | Consent of Ernst & Young LLP, Independent Auditors. | ||
23.2 | Consent of Cooley Godward LLP. Reference is made to Exhibit 5.1. | ||
24.1 | Power of Attorney (contained on the signature page). | ||
99.1 | (3) | 1996 Stock Option Plan, as amended. | |
99.2 | (3) | 2000 Employee Stock Purchase Plan. |
(1) | Incorporated by reference to an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2001. |
(2) | Incorporated by reference to an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003. |
(3) | Incorporated by reference to an exhibit to the Registrant’s Statement on Form S-1, as amended (No. 333-33732), was declared effective on October 4, 2000. |
1
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Hayward, State of California, on September 4, 2003.
KOSAN BIOSCIENCES INCORPORATED | ||
By: | /s/ DANIEL V. SANTI, M.D., PH.D. | |
Daniel V. Santi, M.D., Ph.D. | ||
Chairman and Chief Executive Officer |
POWER OF ATTORNEY
KNOW ALL PERSONSBY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Daniel V. Santi and Susan M. Kanaya, and each or any one of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitutes or substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed on September 4, 2003 by the following persons in the capacities indicated:
Signature | Title | Date | ||
/s/ DANIEL V. SANTI, M.D., PH.D. Daniel V. Santi, M.D., Ph.D. | Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer) | September 4, 2003 | ||
/s/ SUSAN M. KANAYA Susan M. Kanaya | Senior Vice President, Finance, Chief Financial Officer and Secretary (Principal Financial and Accounting Officer) | September 4, 2003 | ||
/s/ BRUCE CHABNER, M.D. Bruce Chabner, M.D. | Director | September 4, 2003 | ||
/s/ PETER DAVIS, PH.D. Peter Davis, Ph.D. | Director | September 4, 2003 |
2
/s/ JEAN DELEAGE, PH.D. Jean Deleage, Ph.D. | Director | September 4, 2003 | ||
/s/ CHARLES HOMCY, M.D. Charles Homcy, M.D. | Director | September 4, 2003 | ||
/s/ CHAITAN KHOSLA, PH.D. Chaitan Khosla, Ph.D. | Director | September 4, 2003 | ||
/s/ CHRISTOPHER WALSH, PH.D. Christopher Walsh, Ph.D. | Director | September 4, 2003 |
INDEX TO EXHIBITS
Exhibit Number | Description | ||
4.1 | (1) | Amended and Restated Certificate of Incorporation of Registrant, as amended to date. | |
4.2 | (2) | Amended and Restated Bylaws of Registrant. | |
4.3 | (3) | Specimen of Common Stock Certificate. | |
5.1 | Opinion of Cooley Godward LLP. | ||
23.1 | Consent of Ernst & Young LLP, Independent Auditors. | ||
23.2 | Consent of Cooley Godward LLP. Reference is made to Exhibit 5.1. | ||
24.1 | Power of Attorney (contained on the signature page). | ||
99.1 | (3) | 1996 Stock Option Plan, as amended. | |
99.2 | (3) | 2000 Employee Stock Purchase Plan. |
(1) | Incorporated by reference to an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2001. |
(2) | Incorporated by reference to an exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003. |
(3) | Incorporated by reference to an exhibit to the Registrant’s Statement on Form S-1, as amended (No. 333-33732), was declared effective on October 4, 2000. |
3